Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medeze Group PCLBKK:MEDEZE -0.81%19 Days Inventory is 74.61 as of Jun. 2026, which is 145% above its 10-year median of 30.42. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Medeze Group PCL ranks worse than 76.33% on this metric.
The historical rank and industry rank for Medeze Group PCL's Days Inventory or its related term are showing as below:
BKK:MEDEZE'
s Days Inventory Range Over the Past 10 Years
Min: 29.26 Med: 30.42 Max: 71.31
Current: 71.31
During the past 3 years, Medeze Group PCL's highest Days Inventory was 71.31. The lowest was 29.26. And the median was 30.42.
BKK:MEDEZE's Days Inventory is ranked worse than 76.33% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 29.56
vs BKK:MEDEZE: 71.31
Medeze Group PCL's Days Inventory
declined
from Jun. 2025 (82.76) to Jun. 2026 (74.61).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medeze Group PCL's Inventory Turnover for the
three
months ended in Jun. 2026 was 1.22.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medeze Group PCL's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.22.
Medeze Group PCL (BKK:MEDEZE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medeze Group PCL's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medeze Group PCL's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medeze Group PCL Days Inventory Related Terms
Medeze Group PCL Days Inventory Historical Data
* Premium members only.
The historical data trend for Medeze Group PCL's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:MEDEZE vs HCA, THC, EHC: Days Inventory Comparison
For the Medical Care Facilities subindustry, Medeze Group PCL's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeze Group PCL Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's Days Inventory distribution charts can be found below:
* The bar in red indicates where Medeze Group PCL's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medeze Group PCL (BKK:MEDEZE) has a Days Inventory of 74.61 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medeze Group PCL and its competitors. This is 145% above median its historical median of 30.42. Over the past decade, Medeze Group PCL's Days Inventory has ranged from 29.26 to 71.31. According to the industry distribution chart, Medeze Group PCL ranks #387 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 76.3%.
Is Medeze Group PCL's Days Inventory too high?
Medeze Group PCL's current Days Inventory of 74.61 is 145% above median its 10-year median of 30.42. Over the past 10 years, this metric has ranged from a low of 29.26 to a high of 71.31. The Healthcare Providers & Services industry median Days Inventory is 29.56. Medeze Group PCL's value of 74.61 is 152.4% above this industry median. Based on the distribution chart, Medeze Group PCL ranks #387 out of 507 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's Days Inventory compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medeze Group PCL ranks #387 out of 507 companies for Days Inventory. This places Medeze Group PCL in the lower half of its industry. The industry median Days Inventory is 29.56. Medeze Group PCL's value of 74.61 is 152.4% above this benchmark. Historically, Medeze Group PCL's own Days Inventory has ranged from 29.26 to 71.31 over the past decade. While the company's 10-year median is 30.42 vs. the industry median of 29.56, Medeze Group PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.56, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medeze Group PCL's current Days Inventory of 74.61 is 152.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medeze Group PCL and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medeze Group PCL's current Days Inventory is 74.61, which is 145% above median its own 10-year median of 30.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current Days Inventory of 74.61. The current Days Inventory is 74.61, which is 145% above median its 10-year median of 30.42 and 152.4% above the Healthcare Providers & Services industry median of 29.56. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current Days Inventory is 74.61 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score
Get the complete analysis for BKK:MEDEZE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MEDEZE has been successfully added to your 
